Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DERMAROME A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.3% 2.3%   Bankruptcy risk   2.3% 2.0% 1.7% 1.3% 1.7% 1.1% 9.4% 9.2%   Credit score (0-100)   67 70 73 78 72 84 26 27   Credit rating   BBB A A A A A BB BB   Credit limit (kDKK)   0.0 0.2 3.0 60.7 3.6 219.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,440 1,836 2,699 3,402 3,138 2,477 0.0 0.0   EBITDA   139 196 798 859 414 638 0.0 0.0   EBIT   139 196 798 859 414 638 0.0 0.0   Pre-tax profit (PTP)   135.1 178.4 806.1 836.5 395.0 572.4 0.0 0.0   Net earnings   135.1 178.4 806.1 836.5 395.0 572.4 0.0 0.0   Pre-tax profit without non-rec. items   135 178 806 836 395 572 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   819 998 1,804 2,640 3,304 3,876 3,376 3,376   Interest-bearing liabilities   206 202 198 193 188 194 0.0 0.0   Balance sheet total (assets)   1,238 1,550 2,623 3,897 4,097 5,099 3,376 3,376   Net Debt   -263 108 -1,473 -2,410 -368 121 -3,376 -3,376     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,440 1,836 2,699 3,402 3,138 2,477 0.0 0.0   Gross profit growth   57.6% 27.5% 47.0% 26.1% -7.7% -21.1% -100.0% 0.0%   Employees   2 3 3 4 4 3 0 0   Employee growth %   0.0% 50.0% 0.0% 33.3% 0.0% -25.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,238 1,550 2,623 3,897 4,097 5,099 3,376 3,376   Balance sheet change%   -1.0% 25.1% 69.3% 48.5% 5.1% 24.5% -33.8% 0.0%   Added value   139.3 196.1 797.5 859.4 414.0 637.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   9.7% 10.7% 29.6% 25.3% 13.2% 25.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.2% 13.8% 39.2% 26.2% 10.4% 14.7% 0.0% 0.0%   ROI %   14.5% 16.9% 48.0% 33.3% 12.9% 17.9% 0.0% 0.0%   ROE %   18.0% 19.6% 57.5% 37.6% 13.3% 15.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   66.2% 64.4% 68.8% 67.8% 80.6% 76.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -188.5% 54.9% -184.7% -280.4% -89.0% 19.0% 0.0% 0.0%   Gearing %   25.1% 20.3% 11.0% 7.3% 5.7% 5.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.0% 6.9% 5.7% 9.8% 11.1% 54.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.4 2.6 3.6 3.3 3.6 2.9 0.0 0.0   Current Ratio   2.4 2.6 3.6 3.3 3.6 2.9 0.0 0.0   Cash and cash equivalent   468.5 94.5 1,671.1 2,603.1 556.5 73.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   574.9 811.2 1,726.1 2,567.9 2,078.6 1,430.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   70 65 266 215 104 213 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   70 65 266 215 104 213 0 0   EBIT / employee   70 65 266 215 104 213 0 0   Net earnings / employee   68 59 269 209 99 191 0 0